2022 Ljubljana, Slovenia

I-36 Anna Mishina
Simulation of Rituximab and Natalizumab biomarker efficacy using simplified QSP model of B- and T- lymphocyte dynamics in Multiple Sclerosis
Wednesday 09:45-11:15